Clinical Trial Update: Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors [NA]

View source ↗

Summary

Completed clinical trial evaluating Blood-Brain Barrier Disruption (BBBD) for liquid biopsy in patients with glioblastoma or glioma, sponsored by InSightec.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Snippet

Sponsor: InSightec | Conditions: Glioblastoma, Glioma | NA | Status: COMPLETED